He Huang

2.7k total citations
78 papers, 1.4k citations indexed

About

He Huang is a scholar working on Oncology, Molecular Biology and Epidemiology. According to data from OpenAlex, He Huang has authored 78 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Oncology, 19 papers in Molecular Biology and 18 papers in Epidemiology. Recurrent topics in He Huang's work include Endometrial and Cervical Cancer Treatments (18 papers), Ovarian cancer diagnosis and treatment (14 papers) and Cervical Cancer and HPV Research (11 papers). He Huang is often cited by papers focused on Endometrial and Cervical Cancer Treatments (18 papers), Ovarian cancer diagnosis and treatment (14 papers) and Cervical Cancer and HPV Research (11 papers). He Huang collaborates with scholars based in China, United States and Japan. He Huang's co-authors include Jihong Liu, Ting Wan, Yanling Feng, Ting Deng, Wenhui Hou, Zeshan You, Xianping Lu, Li Yu, Xiangyuan Wu and Xiao Ke and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and Blood.

In The Last Decade

He Huang

72 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
He Huang China 19 537 480 321 297 217 78 1.4k
Jun Zhu China 20 457 0.9× 450 0.9× 245 0.8× 327 1.1× 128 0.6× 104 1.4k
Jesse S. Voss United States 24 395 0.7× 852 1.8× 223 0.7× 478 1.6× 167 0.8× 70 2.0k
Ewan Brown United Kingdom 18 510 0.9× 501 1.0× 97 0.3× 238 0.8× 59 0.3× 30 1.2k
Kim A. Reiss United States 19 452 0.8× 971 2.0× 189 0.6× 444 1.5× 103 0.5× 63 1.4k
Holger W. Hirte Canada 20 763 1.4× 978 2.0× 87 0.3× 305 1.0× 92 0.4× 46 2.0k
Pilar Lardelli Spain 19 298 0.6× 643 1.3× 334 1.0× 141 0.5× 276 1.3× 71 1.5k
J.Y. Scoazec France 16 425 0.8× 450 0.9× 347 1.1× 124 0.4× 210 1.0× 35 1.2k
Pierre Combe France 13 373 0.7× 916 1.9× 74 0.2× 328 1.1× 118 0.5× 42 1.5k
Ming‐Chu Chang Taiwan 26 431 0.8× 847 1.8× 367 1.1× 320 1.1× 46 0.2× 69 1.9k

Countries citing papers authored by He Huang

Since Specialization
Citations

This map shows the geographic impact of He Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by He Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites He Huang more than expected).

Fields of papers citing papers by He Huang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by He Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by He Huang. The network helps show where He Huang may publish in the future.

Co-authorship network of co-authors of He Huang

This figure shows the co-authorship network connecting the top 25 collaborators of He Huang. A scholar is included among the top collaborators of He Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with He Huang. He Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, He, Ziyan Lu, Meifeng Chen, et al.. (2025). Comprehensive Pan-Cancer Analysis and Functional Studies Reveal SLC2A6 as a Ferroptosis Modulator in Hepatocellular carcinoma. Scientific Reports. 15(1). 2545–2545. 1 indexed citations
2.
Chen, Jianhong, et al.. (2025). How feeling loved inspires the purchase of green foods. Journal of Environmental Psychology. 102. 102523–102523. 1 indexed citations
3.
4.
5.
6.
Hong, Huangming, Mingzhi Zhang, Zhigang Peng, et al.. (2023). A Multicenter, Open-Label, Single-Arm, Phase Ib Clinical Trial of HH2853 in the Treatment of Patients with Relapsed and/or Refractory Peripheral T-Cell Lymphoma. Blood. 142(Supplement 1). 304–304. 2 indexed citations
7.
Deng, Xinyi, Le Yu, Huangming Hong, et al.. (2023). Discontinuation and nonpublication of nasopharyngeal carcinoma clinical trials. Oral Oncology. 148. 106656–106656. 1 indexed citations
8.
Deng, Xinyi, Le Yu, Zhao Wang, et al.. (2023). Characteristics of immunotherapy trials for nasopharyngeal carcinoma over a 15-year period. Frontiers in Immunology. 14. 1195659–1195659. 1 indexed citations
9.
He, Wenting, Jieping Chen, Yun Zhou, et al.. (2023). Mitophagy genes in ovarian cancer: a comprehensive analysis for improved immunotherapy. Discover Oncology. 14(1). 221–221. 2 indexed citations
10.
Feng, Yanling, et al.. (2023). Impact of different post-operative treatment modalities on long-term outcomes in International Federation of Gynecology and Obstetrics (FIGO) 2018 stage IIICp cervical cancer. International Journal of Gynecological Cancer. 33(6). 882–889. 1 indexed citations
11.
Chen, Limin, Zhao Wang, Qiuyan Xu, et al.. (2022). Prognostic value of the modified systemic inflammation score in non-small-cell lung cancer with brain metastasis. Cancer Cell International. 22(1). 320–320. 7 indexed citations
12.
13.
Xu, Yun, Mengwei Chen, Qiaojuan Guo, et al.. (2021). Percutaneous endoscopic gastrostomy can improve survival outcomes in patients with N3 nasopharyngeal carcinoma undergoing concurrent chemoradiotherapy. Oral Oncology. 121. 105435–105435. 3 indexed citations
14.
Dai, Danian, He Huang, Yanling Feng, et al.. (2020). Minimally invasive surgery vs laparotomy for early stage cervical cancer: A propensity score‐matched cohort study. Cancer Medicine. 9(24). 9236–9245. 9 indexed citations
15.
Feng, Yanling, et al.. (2019). Comparison of PARPis with Angiogenesis Inhibitors and Chemotherapy for Maintenance in Ovarian Cancer: A Network Meta-Analysis. Advances in Therapy. 36(12). 3368–3380. 12 indexed citations
16.
Feng, Yanling, Fan He, Shumei Yan, et al.. (2017). The Role of GOLPH3L in the Prognosis and NACT response in Cervical Cancer. Journal of Cancer. 8(3). 443–454. 5 indexed citations
17.
Feng, Yanling, Tiefeng Cao, Yin Wang, et al.. (2016). Neoadjuvant chemotherapy followed by conization to spare fertility in cases of locally advanced cervical cancer: A case report and review of the literature. Molecular and Clinical Oncology. 5(4). 411–416. 6 indexed citations
18.
Shi, Yue, Mei Dong, Xiaoting Hong, et al.. (2015). Results from a multicenter, open-label, pivotal phase II study of chidamide in relapsed or refractory peripheral T-cell lymphoma. Annals of Oncology. 26(8). 1766–1771. 263 indexed citations
19.
Huang, Qidan, He Huang, Ting Wan, Ting Deng, & Jihong Liu. (2013). Clinical outcome of 31 patients with primary malignant melanoma of the vagina. Journal of Gynecologic Oncology. 24(4). 330–330. 28 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jun Zhu Breakdown of academic impact, for papers by Jesse S. Voss Breakdown of academic impact, for papers by Ewan Brown Breakdown of academic impact, for papers by Kim A. Reiss Breakdown of academic impact, for papers by Holger W. Hirte Breakdown of academic impact, for papers by Pilar Lardelli Breakdown of academic impact, for papers by J.Y. Scoazec Breakdown of academic impact, for papers by Pierre Combe Breakdown of academic impact, for papers by Ming‐Chu Chang
Rankless by CCL
2026